Practice by content domain
- Clinical Management (57%)
- Nutrition Assessment (31%)
- Professional Practice (7%)
- Process Management (5%)
- Calculations practice (8 worked questions)
Eight mixed CNSC questions
A 58-year-old man receives continuous EN through a gastrostomy. At 0900 he is due for two immediate-release medications, one liquid and one crushed tablet, neither of which requires separation from EN. Fluid status allows routine flushes. Which administration sequence is most appropriate?
Show answer and explanation
Answer: A. Stop EN; flush 15 mL; drug 1; flush 15 mL; drug 2; flush 15 mL; restart EN
A (correct): ASPEN safe practices call for stopping the feeding, flushing with at least 15 mL water, giving each medication separately with a clean enteral syringe, flushing at least 15 mL between and after medications, and restarting the feeding promptly. Holding EN 30 minutes or more is needed only when separation is indicated for bioavailability.
B (incorrect): Mixing medications risks physical and chemical incompatibility, tube obstruction and altered drug response. Giving drugs while formula runs also invites drug-formula interactions in the tube.
C (incorrect): Giving the drugs without a flush before and between them lets them mix in the tube and contact residual formula. Each medication should be separated by a water flush.
D (incorrect): Five-mL flushes are below the adult minimum of 15 mL, the drugs are still given together, and holding EN for 2 hours without an indication needlessly reduces nutrition delivery.
Reference: Boullata JI, Carrera AL, Harvey L, et al. ASPEN safe practices for enteral nutrition therapy. JPEN J Parenter Enteral Nutr. 2017;41(1):15-103. Section 8, Question 8.2 Practice Recommendations 7 to 9, 14 and 15. https://doi.org/10.1177/0148607116673053
A 59-year-old woman with type 2 diabetes receives nocturnal gastrostomy feeding and eats small meals by day. While on prednisone 60 mg each morning, she needed NPH 20 units with the prednisone dose in addition to her usual glargine, and her glucose is now 120 to 170 mg/dL. Starting tomorrow, prednisone will be tapered by 10 mg every 2 days. Which plan for her NPH insulin is most appropriate?
Show answer and explanation
Answer: D. Lower the NPH dose as each prednisone reduction is made, guided by glucose checks
A (incorrect): Waiting for hypoglycemia before changing insulin is unsafe. A falling steroid dose predictably lowers the insulin requirement, so the dose should be reduced in anticipation.
B (incorrect): She will still receive 50 mg prednisone tomorrow, so stopping all NPH at once would likely cause marked afternoon and evening hyperglycemia. The reduction should be stepwise, in line with the taper.
C (incorrect): Her NPH is matched to the morning steroid peak. Moving it to bedtime changes its purpose and could cause nocturnal hypoglycemia as the steroid effect wanes, while leaving afternoon steroid hyperglycemia uncovered.
D (correct): The 2026 ADA hospital standards stress daily insulin adjustment based on glucose levels and anticipated changes in the type, dose and duration of glucocorticoids. Reducing NPH in step with each prednisone reduction, with point-of-care glucose monitoring, limits both hypoglycemia and hyperglycemia.
Reference: American Diabetes Association Professional Practice Committee for Diabetes. 16. Diabetes care in the hospital: Standards of Care in Diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S339-S355. Section: Glucocorticoid Therapy. https://doi.org/10.2337/dc26-S016
A 73-year-old man (61 kg) has a gastrostomy with an internal balloon and an adjustable external disc. Over 2 days he has developed crampy upper abdominal pain and vomits after each bolus feeding. On examination the external disc has slid outward along the tube and now sits about 6 cm from the skin, and the external tube length is shorter than documented. Which explanation is most likely?
Show answer and explanation
Answer: D. Inward migration with the balloon blocking the gastric outlet
A (incorrect): Buried bumper syndrome results from a bolster that is too tight, drawing the internal bumper into the gastric wall. Here the disc is loose and the tube has moved inward. The mechanism is the opposite.
B (incorrect): Leakage presents with drainage and skin irritation at the stoma, not with vomiting after feeds. A loose bolster can cause leakage, but it does not explain obstructive symptoms. The vomiting points to the outlet.
C (incorrect): A clogged tube prevents formula from entering the stomach and would not cause vomiting after each feed. Occlusion also does not change the external disc position. The findings point to tube migration.
D (correct): When the external bolster migrates away from the abdominal wall, the tube can be pulled forward by peristalsis toward the pylorus or duodenum. The balloon or bumper then obstructs the gastric outlet, causing cramps, nausea and vomiting. Keeping the external bumper about 1 to 2 cm from the skin is the key preventive step.
Reference: Rahnemai-Azar AA, Rahnemaiazar AA, Naghshizadian R, et al. Percutaneous endoscopic gastrostomy: indications, technique, complications and management. World J Gastroenterol. 2014;20(24):7739-7751. Minor complications, Gastric outlet obstruction and Tube dislodgment. https://pmc.ncbi.nlm.nih.gov/articles/PMC4069302/
A 1.0-kg infant born at 27 weeks is on day 3 of PN with soybean oil lipid injectable emulsion at 1 g/kg/day. Triglycerides are 110 mg/dL and liver tests are normal. A colleague suggests keeping the lipid at 1 g/kg/day for the whole PN course. Which plan is most consistent with the 2023 ASPEN preterm PN guideline?
Show answer and explanation
Answer: C. Advance lipid daily toward 3 g/kg/day while monitoring triglycerides
A (incorrect): ASPEN (2023) does not recommend routinely reducing amino acid, dextrose or lipid doses to prevent PNALD in preterm infants. Prolonged lipid restriction risks inadequate growth and essential fatty acid deficiency.
B (incorrect): ASPEN recommends against reducing the lipid dose to prevent sepsis. A lower dose would also cut energy and essential fatty acid delivery.
C (correct): ASPEN recommends daily advancement of soybean or multicomponent lipid emulsion to 3 g/kg/day to support growth, with attention to fatty acid content. Triglyceride monitoring during advancement guards against intolerance.
D (incorrect): ASPEN found no evidence that any specific lipid emulsion, including fish oil-containing products, prevents PNALD in preterm infants. Fish oil emulsion at 1 g/kg/day is labeled as a source of calories and fatty acids in pediatric patients who already have PN-associated cholestasis, not for prevention.
Reference: Robinson DT, Calkins KL, Chen Y, et al. Guidelines for parenteral nutrition in preterm infants: the American Society for Parenteral and Enteral Nutrition. JPEN J Parenter Enteral Nutr. 2023;47(7):830-858 (ASPEN practice tool reprint, 2023). Questions 4, 6, 7a, 7b and 9 recommendations. https://nutritioncare.org/wp-content/uploads/2025/02/NICU-PN-Guidelines-Practice-Tool.pdf
A 57-year-old woman with acute necrotizing pancreatitis has an estimated energy need of 2,000 kcal/day. Calorie counts for the past 5 days were 850, 900, 1,000, 800 and 950 kcal. The physical exam shows moderate temporal and clavicular muscle loss. She has no chronic illness. What percentage of her estimated needs has she eaten, and what does this intake support?
Show answer and explanation
Answer: B. 45%; the severe intake threshold
Worked calculation
- Step 1: Total intake = 850 + 900 + 1,000 + 800 + 950 = 4,500 kcal over 5 days.
- Step 2: Mean intake = 4,500 / 5 = 900 kcal/day.
- Step 3: Percentage of needs = 900 / 2,000 x 100 = 45%.
- Step 4: In acute illness, intake of 50% or less for at least 5 days is a severe characteristic.
- Result: 45% for 5 days meets the severe intake threshold; moderate muscle loss is a second severe acute characteristic.
A (incorrect): The percentage is right, but intake of 50% or less for at least 5 days is the severe acute threshold. The non-severe threshold (below 75% for more than 7 days) is less strict.
B (correct): Mean intake is 900 kcal/day, or 45% of 2,000 kcal. Intake at or below 50% for at least 5 days is a severe characteristic in acute illness, and moderate muscle loss is also a severe acute finding, supporting severe malnutrition.
C (incorrect): This reports the deficit (1,100 / 2,000) rather than intake. Even 55% for 5 days would not meet the non-severe threshold, which requires more than 7 days.
D (incorrect): The intake is calculated as the deficit. The correct figure, 45%, meets the severe acute threshold.
Reference: White JV, Guenter P, Jensen G, et al. Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition). J Acad Nutr Diet. 2012;112(5):730-738. Table, characteristics 1 and 4, acute illness or injury columns. https://www.andeal.org/files/Docs/White%202012%20Malnutrition%20Consensus%20-%20Table%20Clinical%20Characteristics.pdf
A 70-year-old woman on home enteral nutrition has serum magnesium 1.0 mg/dL. Her 24-hour urine magnesium excretion is appropriately low, suggesting a non-renal cause. Which of the following medications is the most likely contributor?
Show answer and explanation
Answer: A. Omeprazole taken daily for 6 years
A (correct): Proton pump inhibitors reduce intestinal magnesium absorption, and urinary magnesium excretion is appropriately low in this form of hypomagnesemia. Long-term use is a common, often overlooked cause in patients on nutrition support.
B (incorrect): Calcineurin inhibitors cause hypomagnesemia mainly through renal magnesium wasting. Urine magnesium would be inappropriately high, not low.
C (incorrect): Aminoglycosides injure the renal tubule and cause urinary magnesium wasting. The low urinary excretion here points away from a renal cause.
D (incorrect): Loop diuretics increase urinary magnesium losses. A renal mechanism does not fit an appropriately low urinary magnesium.
Reference: Liamis G, Hoorn EJ, Florentin M, et al. An overview of diagnosis and management of drug-induced hypomagnesemia. Pharmacol Res Perspect. 2021;9(4):e00829. Section 4 (drugs associated with hypomagnesemia; 4.5 proton pump inhibitors). https://pmc.ncbi.nlm.nih.gov/articles/PMC8287009/
A hospital will begin sending home PN orders electronically from its EHR to outside home infusion pharmacies next quarter. Before launch, the nutrition support team wants to identify how the new process could fail, why each failure could happen, and what the consequences would be. Which quality tool is most appropriate?
Show answer and explanation
Answer: D. Failure modes and effects analysis of each step of the new process
A (incorrect): Root cause analysis looks back at an event that has already happened. It cannot systematically identify failure points in a process that has not yet started.
B (incorrect): A run chart displays performance over time but does not identify failure modes. It also describes the old process, not the new one.
C (incorrect): An audit measures past documentation quality. It does not examine steps, failure modes, causes and effects in a new workflow.
D (correct): IHI describes FMEA as a systematic, proactive method for evaluating a process to identify where and how it might fail, why, and with what effects, and notes that it is particularly useful for evaluating a new process before implementation.
Reference: Institute for Healthcare Improvement. Failure Modes and Effects Analysis (FMEA) Tool (web page). IHI. Tool description (steps, failure modes, failure causes, failure effects; particularly useful before implementing a new process). https://www.ihi.org/library/tools/failure-modes-and-effects-analysis-fmea-tool
A 76-year-old Medicare beneficiary with chronic obstructive pulmonary disease and unintentional weight loss is discharged home. She can swallow safely and has a functioning gastrointestinal tract. The team recommends a standard oral nutrition supplement twice daily and asks whether Medicare Part B will pay for it under the enteral nutrition benefit. What is the most accurate answer?
Show answer and explanation
Answer: D. No, because orally administered enteral nutrition products are noncovered under the Part B benefit
A (incorrect): Medicare coverage depends on the benefit category and policy criteria, not on whether a product is a medical food. Enteral nutrition is covered under the prosthetic device benefit only for qualifying beneficiaries who need tube feeding.
B (incorrect): Duration of weight loss is not the coverage test. The policy requires a permanent impairment that necessitates feeding through an enteral access device.
C (incorrect): Food thickeners and regular grocery products are themselves noncovered, and a failed trial of them does not create coverage for an oral supplement.
D (correct): The DME MAC policy article states that orally administered enteral nutrition products and related supplies are denied as non-covered. Enteral nutrition is covered under the prosthetic device benefit for beneficiaries with a permanent impairment who require feeding through an enteral access device.
Reference: Centers for Medicare & Medicaid Services, DME MACs. Enteral Nutrition: Policy Article (A58833), revision effective October 1, 2023. Coverage Indications, Limitations and Medical Necessity; Non-Medical Necessity Coverage and Payment Rules. https://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=58833
For exam preparation only, not clinical advice.
How did you do?
Eight questions are too few to predict your result, but they show whether the style suits you and where to look first. The real exam has 250 questions in four hours, and Clinical Management alone is 57% of it. Each domain page above has a short study guide and more free questions, and the CNSC exam 2027 page has the dates, fees and format.
Practice the whole content outline, not just a handful of questions
Get 550+ practice questions across all four domains, a timed full-length mock (250 questions in 4 hours) or half-length mock (125 in 2 hours), worked steps for every calculation, and a rationale with its source for every answer, backed by a pass-or-refund guarantee. $199 USD, one time.
See the full question bankOne-time purchase · No subscription · Pass-or-refund guarantee